(Q34133049)

31 July 2017

1 reference

title

The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae (English)

1 reference

31 July 2017

Streptococcus pneumoniae

1 reference

Briles DE

1

1 reference

31 July 2017

Hollingshead SK

2

1 reference

31 July 2017

Nabors GS

3

1 reference

31 July 2017

Paton JC

4

1 reference

31 July 2017

Brooks-Walter A

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

31 July 2017

1 reference

31 July 2017

19 Suppl 1

1 reference

31 July 2017

S87-95

1 reference

Use of conjugate vaccines to prevent meningitis caused by Haemophilus influenzae type b or Streptococcus pneumoniae

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Six newly recognized types of Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Carriage of pneumococci after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Antigen-Independent Selection of T15 Idiotype During B-Cell Ontogeny In Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Novel pneumococcal surface proteins: role in virulence and vaccine potential

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

A comprehensive genetic study of streptococcal immunoglobulin A1 proteases: evidence for recombination within and between species

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Effects of active immunization with a pneumococcal surface protein (PspA) and of locally applied antibodies in experimental otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Current options for vaccine delivery systems by mucosal routes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Systemic and mucosal protective immunity to pneumococcal surface protein A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900285-1

7 January 2021

10.1016/S0264-410X(00)00285-1

Identifiers

DOI

1 reference

31 July 2017

1 reference